Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease

Assessment of acetylcholinesterase activity in CD9-positive exosomes from patients with Parkinson’s disease

IntroductionParkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic dysfunction and associated with abnormalities in the cholinergic system. However, the relationship between PD and cholinergic dysfunction, particularly in exosomes, is not fully understood.MethodsWe en...

Full description

Bibliographic Details
Main Authors:	Sumin Jeong, Kyu Hwan Shim, Danyeong Kim, Heewon Bae, Da-Eun Jeong, Min Ju Kang, Seong Soo A. An
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson’s disease blood acetylcholinesterase exosomes CD9 cholinergic dysfunction
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2024.1332455/full

Similar Items

Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson’s Disease
by: Kyu Hwan Shim, et al.
Published: (2021-05-01)

Corrigendum: Decreased Exosomal Acetylcholinesterase Activity in the Plasma of Patients With Parkinson's Disease
by: Kyu Hwan Shim, et al.
Published: (2021-07-01)

Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data
by: Deborah Baik, et al.
Published: (2022-07-01)

Acetylcholinesterase and Butyrylcholinesterase – Important Enzymes of Human Body
by: Jiří Patočka, et al.
Published: (2004-01-01)

Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with <i>CNR1 rs806368</i> and <i>ACHE rs17228602</i>
by: Tiyyaba Furqan, et al.
Published: (2020-05-01)

AChE-activity in critically ill patients with suspected septic encephalopathy: a prospective, single-centre study
by: Benedikt Zujalovic, et al.
Published: (2020-11-01)

A Possible Pathogenic PSEN2 Gly56Ser Mutation in a Korean Patient with Early-Onset Alzheimer’s Disease
by: Kyu-Hwan Shim, et al.
Published: (2022-03-01)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
by: Łucja Justyna Walczak-Nowicka, et al.
Published: (2021-08-01)

Ultrafast and Slow Cholinergic Transmission. Different Involvement of Acetylcholinesterase Molecular Forms
by: Yves Dunant, et al.
Published: (2017-08-01)

The role of exosomes in the diagnosis of Parkinson's disease
by: Qingqing Shi, et al.
Published: (2023-10-01)

Detection of Exosomes Using Total Internal Reflected Imaging Ellipsometry
by: Haoyu Liu, et al.
Published: (2021-05-01)

Acetylcholinesterase involvement in apoptosis
by: Xue-Jun eZhang, et al.
Published: (2012-04-01)

Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
by: Dimitrios S. Mysiris, et al.
Published: (2022-08-01)

Effects of altered gravity induced by clinorotation on the cholinesterase activity of the non-sentient model Paramecium primaurelia (Protozoa)
by: Francesca Sardi, et al.
Published: (2018-05-01)

Development Of An Inhibitive Acetylcholinesterase-Based Assay For Insecticides
by: Tham, Lik Gin
Published: (2008)

Acetylcholinesterase is not a generic marker of extracellular vesicles
by: Zhaohao Liao, et al.
Published: (2019-12-01)

Molecular docking and acetylcholinesterase inhibitory activity of psoralen derivatives /
by: Natasha Amira Kamarudin, 1992-, author 639897, et al.
Published: (2020)

Molecular docking and acetylcholinesterase inhibitory activity of psoralen derivatives /
by: Natasha Amira Kamarudin, 1992-, author 639897
Published: (2020)

Synthesis and characterization of new chalcone derivatives as acetylcholinesterase inhibitor /
by: Arman Abdalla Ali, 1984-, author 639910, et al.
Published: (2020)

Synthesis and characterization of new chalcone derivatives as acetylcholinesterase inhibitor /
by: Arman Abdalla Ali, 1984-, author 639910
Published: (2020)

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
by: Maria Izco, et al.
Published: (2022-05-01)

Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives
by: Igor A. Schepetkin, et al.
Published: (2023-04-01)

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
by: Aojie He, et al.
Published: (2023-07-01)

Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients
by: Foteinos-Ioannis Dimitrakopoulos, et al.
Published: (2021-10-01)

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
by: Kandiah N, et al.
Published: (2017-04-01)

Cholinergic Stress Signals Accompany MicroRNA-Associated Stereotypic Behavior and Glutamatergic Neuromodulation in the Prefrontal Cortex
by: Gilli Moshitzky, et al.
Published: (2020-06-01)

Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders
by: Bettina eNadorp, et al.
Published: (2014-02-01)

Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01)

Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model
by: Mehmet Enes Arslan, et al.
Published: (2023-03-01)

Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
by: Haiyang Yu, et al.
Published: (2020-02-01)

Fast Intracortical Sensory-Motor Integration: A Window Into the Pathophysiology of Parkinson’s Disease
by: Raffaele Dubbioso, et al.
Published: (2019-04-01)

Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications
by: Yassamine Ouerdane, et al.
Published: (2022-01-01)

"In vitro inhibition of human erythrocyte Acetylcholinesterase activity by Zinc and Mercury "
by: "Abdollahi M, et al.
Published: (2000-10-01)

High Efficiency Acetylcholinesterase Immobilization on DNA Aptamer Modified Surfaces
by: Orada Chumphukam, et al.
Published: (2014-04-01)

"In vitro inhibition of human erythrocyte Acetylcholinesterase activity by Zinc and Mercury "
by: "Abdollahi M, et al.
Published: (2000-09-01)

The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
by: Reza Mosaddeghi Heris, et al.
Published: (2022-07-01)

Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
by: Kumar Gajendra, et al.
Published: (2024-08-01)

Influence of a genetic variant of CHAT gene over the profile of plasma soluble ChAT in Alzheimer disease
by: Patricia Fernanda Rocha-Dias, et al.
Published: (2020-11-01)

Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer’s-like Tauopathy Mouse Model
by: Maciej Zadrozny, et al.
Published: (2024-04-01)

Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects
by: Unnur D. Teitsdottir, et al.
Published: (2022-05-01)